| Code | Name | Last | Change(%) | P/E | Yield (%) | P/E Range | ||
| MNKD | MannKind Corp |  | 5.03 | +1.21% | 49.7 | -- |  | |
| Pre Market | | 5.11 | +1.59% | |||||
| BBOT | BridgeBio Oncology Therapeutics Inc | | 12.39 | +1.72% | 48.16 | -- | | |
| Pre Market |  | -- | -- | |||||
| LENZ | LENZ Therapeutics | | 29.56 | +6.64% | 45.35 | 32.39 | | |
| Pre Market | | 30.4 | +2.84% | |||||
| GLUE | Monte Rosa Therapeutics | | 14.22 | +5.18% | 42.25 | -- | | |
| Pre Market |  | 14.11 | -0.77% | |||||
| KRYS | Krystal Biotech | | 212.02 | +3.82% | 41.51 | -- | | |
| Pre Market | | 215 | +1.41% | |||||
| STOK | Stoke Therapeutics | | 29.34 | +5.05% | 41.07 | -- | | |
| Pre Market | | 28.39 | -3.24% | |||||
| ARGX | argenx SE | | 918.92 | +0.05% | 39.29 | -- | | |
| Pre Market | | 916.3 | -0.29% | |||||
| CSBR | Champions Oncology | | 6.77 | +1.65% | 31.71 | 1.45 | | |
| Pre Market | | -- | -- | |||||
| IMTX | Immatics NV | | 10.2 | +0.99% | 29.95 | -- | | |
| Pre Market | | 10.4 | +1.96% | |||||
| VRTX | Vertex Pharmaceuticals | | 426.76 | +1.05% | 29.84 | -- | | |
| Pre Market | | 425.21 | -0.36% | |||||
| NAGE | Niagen Bioscience Inc | | 6.88 | +2.53% | 27.96 | -- | | |
| Pre Market | | 6.95 | +1.02% | |||||
| AUPH | Aurinia Pharmaceuticals | | 15.68 | +3.57% | 27.16 | -- | | |
| Pre Market | | 15.95 | +1.72% | |||||
| CTNM | Contineum Therapeutics | | 10.945 | -10.43% | 26.3 | -- | | |
| Pre Market | | -- | -- | |||||
| SMMT | Summit Therapeutics | | 16.19 | -1.58% | 25.11 | -- | | |
| Pre Market | | 16.22 | +0.19% | |||||
| MDXG | MiMedx Group | | 6.76 | +3.21% | 24.26 | -- | | |
| Pre Market | | 6.6 | -2.37% | |||||
| MCRB | Seres Therapeutics Inc | | 17.71 | -18.39% | 23.85 | -- | | |
| Pre Market | | 17.71 | 0.00% | |||||
| RPRX | Royalty Pharma plc | | 38.92 | +1.38% | 21.94 | 2.26 | | |
| Pre Market | | -- | -- | |||||
| ICCC | ImmuCell Corp | | 4.68 | +1.74% | 21.9 | -- | | |
| Pre Market | | -- | -- | |||||
| RAPP | Rapport Therapeutics Inc. | | 27.25 | +1.49% | 21.13 | -- | | |
| Pre Market | | -- | -- | |||||
| ORMP | Oramed Pharmaceuticals | | 2.58 | +6.61% | 20.09 | -- | | |
| Pre Market | | 2.6 | +0.78% | |||||
 | Quotes are at least 15-min delayed：2025/11/24 06:05 EDT |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |